Home
Home » Monthly archive

April 2012

Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May

Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville

Is This Biotech Trying to Distract Investors?

Is This Biotech Trying to Distract Investors?
Motley Fool

Double-Digit Upside For Merck, Mylan Tops BioPharma

Double-Digit Upside For Merck, Mylan Tops BioPharma
Seeking Alpha

Watson Q1 Beats Expectations; Eyes Actavis Closing

Watson Q1 Beats Expectations; Eyes Actavis Closing
Investors.com

Vivus: Who Leaked Word Of Stendra Approval?

Vivus: Who Leaked Word Of Stendra Approval?
Seeking Alpha

Dynavax: Let The Show Begin!

Dynavax: Let The Show Begin!
Seeking Alpha

MannKind says it could get $130M and royalties after licensing drug candidates to Tolero

MannKind says it could get $130M and royalties after licensing drug candidates to Tolero
Yahoo/AP

Teva settles Nuvigil litigation with Mylan

Teva settles Nuvigil litigation with Mylan
Yahoo/Businesswire

Warner Chilcott says it's in early talks that could lead to sale of company, shares soar

Warner Chilcott says it's in early talks that could lead to sale of company, shares soar
Yahoo/AP

Biotech venture rounds dwindle in Europe, tracking U.S. trend

Biotech venture rounds dwindle in Europe, tracking U.S. trend
Fierce Biotech